(300 MHz, CDCl3): d 3.94 (s, 3H), 3.97 (s, 3H), 6.92 (d, J = 7.8 Hz,
1H), 6.96 (ddd, J = 1.2, 7.5, 7.5 Hz, 1H), 7.10 (d, J = 1.2 Hz, 1H),
7.17 (dd, J = 1.2, 7.8 Hz, 1H), 7.33 (ddd, J = 1.8, 7.8, 8.1 Hz, 1H),
7.47 (ddd, J = 1.5, 7.2, 7.5 Hz, 1H), 7.51 (dd, J = 1.2, 7.2 Hz, 1H)
7.54 (d, J = 8.1 Hz, 1H), 7.61 (ddd, J = 1.2, 7.8, 7.8 Hz, 1H), 7.64
(d, J = 7.8 Hz, 1H), 7.65 (dd, J = 0.3, 8.4 Hz, 1H), 7.71 (ddd,
J = 0.3, 1.5, 7.8 Hz, 1H), 7.77 (dd, J = 1.5, 8.4 Hz, 1H), 7.88 (d,
J = 1.5 Hz, 1H). 13C NMR (75.4 MHz, CDCl3): d 55.95, 56.11,
88.20, 88.95, 90.89, 93.09, 93.15, 95.01, 110.58, 110.73, 111.09,
111.89, 113.86, 113.88, 115.50, 115.54, 115.61, 116.66, 116.69,
117.29, 122.21, 126.12, 126.17, 126.22, 127.60, 127.63, 132.13,
132.74, 133.18, 133.46, 134.60, 135.89, 159.96, 160.06. HR MS
(FAB, positive ion mode) calcd for C34H20N2O2 488.1525, found
488.1520.
5-[(2-Cyanophenyl)-ethynyl]-2- [[2-methoxy-4- [[2-methoxy-4-
[(2-methoxyphenyl)-ethynyl]- phenyl]-ethynyl]- phenyl]- ethynyl]-
benzonitrile (BL-8). The reaction of 13 (797 mg, 2.03 mmol)
with 5-bromo-2-iodobenzonitrile (520 mg, 1.69 mmol) for 1 h at
ambient temperature provided bromide 16 (842 mg, 1.47 mmol,
87%). By the general procedure the reaction of 7 (140 mg, 1.10
mmol) with bromide 16 (527 mg, 0.92 mmol) was completed
after 12 h (reflux). The crude product was purified by column
chromatography (benzene) followed by recrystallization from
benzene to provide BL-8 (455 mg, 80%) as yellow crystals. M.p.
194–195 ◦C. 1H NMR (300 MHz, CDCl3): d 3.94 (s, 3H), 3.96 (s,
3H), 3.98 (s, 3H), 6.92 (d, J = 7.5 Hz, 1H), 6.96 (ddd, J = 1.2, 7.8,
7.8 Hz, 1H), 7.10 (bs, 2H), 7.17 (ddd, J = 1.5, 1.5, 7.8 Hz, 2H),
7.34 (ddd, J = 1.8, 7.2, 7.5 Hz, 1H), 7.46 (dd, J = 1.8, 7.2 Hz,
1H), 7.47 (d, J = 8.1 Hz, 1H), 7.50 (ddd, J = 1.8, 7.2, 7.2 Hz, 1H),
7.55 (d, J = 7.8 Hz, 1H), 7.61 (ddd, J = 1.5, 8.1, 8.1 Hz, 1H), 7.65
(ddd, J = 0.9, 1.2, 8.1 Hz, 1H), 7.66 (d, J = 8.1 Hz, 1H), 7.72 (ddd,
J = 0.9, 1.5, 7.2 Hz, 1H), 7.77 (dd, J = 1.8, 8.1 Hz, 1H), 7.88 (d,
J = 1.2 Hz, 1H). 13C NMR (75.4 MHz, CDCl3): d 55.85, 56.13,
56.13, 87.71, 88.08, 88.97, 91.00, 93.15, 93.15, 94.59, 94.98, 110.54,
111.24, 111.96, 113.37, 113.81, 113.81, 113.81, 115.50, 115.63,
116.69, 117.30, 120.63, 122.24, 123.90, 124.43, 125.16, 125.99,
126.12, 127.60, 131.32, 132.17, 132.41, 132.78, 133.59, 134.42,
134.60, 135.54, 135.88, 136.64, 159.59, 159.93, 160.07. HR MS
(FAB, positive ion mode) calcd for C43H26N2O3 618.1943, found
618.1941.
5-[[2-Cyano-4- [(2-cyanophenyl)-ethynyl]-phenyl]-ethynyl]-2-[[2-
methoxy-4- [(2-methoxyphenyl)-ethynyl]-phenyl]-ethynyl]-benzo-
nitrile (BL-6). By the general procedure the reaction of 8
(293 mg, 1.16 mmol) with bromide 15 (429 mg, 0.97 mmol)
was completed after 12 h (reflux). The crude product was
purified by column chromatography (benzene) followed by
recrystallization from benzene◦to provide BL-6 (386 mg, 65%) as
1
yellow crystals. M.p. 221–222 C. H NMR (300 MHz, CDCl3):
d 3.94 (s, 3H), 3.98 (s, 3H), 6.92 (d, J = 7.5 Hz, 1H), 6.96 (ddd,
J = 1.2, 7.5, 7.5 Hz, 1H), 7.10 (d, J = 1.2 Hz, 1H), 7.17 (dd,
J = 1.2, 7.5 Hz, 1H), 7.34 (ddd, J = 1.8, 7.8, 8.4 Hz, 1H), 7.49
(ddd, J = 1.5, 7.2, 7.5 Hz, 1H), 7.51 (dd, J = 1.2, 7.2 Hz, 1H),
7.53 (d, J = 7.8 Hz, 1H), 7.62 (ddd, J = 1.2, 7.8, 7.8 Hz, 1H),
7.65 (dd, J = 1.2, 8.1 Hz, 1H), 7.66 (dd, J = 0.9, 8.4, Hz, 1H),
7.66 (d, J = 8.1 Hz, 1H), 7.72 (ddd, J = 0.9, 1.5, 7.2 Hz, 1H),
7.77 (dd, J = 1.5, 8.1 Hz, 1H), 7.81 (dd, J = 1.5, 8.4 Hz, 1H),
7.88 (d, J = 1.5 Hz, 1H), 7.90 (d, J = 1.5 Hz, 1H). 13C NMR
(75.4 MHz, CDCl3): d 55.83, 56.12, 88.26, 88.76, 89.57, 90.91,
92.77, 93.09, 95.31, 95.36, 110.79, 111.04, 111.89, 113.44, 113.87,
115.67, 115.67, 116.02, 116.43, 116.63, 117.25, 120.65, 121.87,
123.32, 123.90, 125.91, 126.23, 126.27, 127.92, 131.36, 132.20,
132.27, 132.45, 132.81, 133.26, 133.53, 133.93, 134.67, 135.58,
135.95, 136.70, 159.96, 160.13. HR MS (FAB, positive ion mode)
calcd for C43H23N3O2 613.1790, found 613.1783.
5-[[2-Cyano-4- [(2-cyanophenyl)-ethynyl]-phenyl]-ethynyl]-2-[[2-
methoxy-4- [[2-methoxy-4- [(2-methoxyphenyl)- ethynyl]-phenyl]-
ethynyl]-phenyl]-ethynyl]-benzonitrile (BL-9). By the general pro-
cedure the reaction of 8 (166 mg, 0.66 mmol) with bromide 16
(315 mg, 0.55 mmol) was completed after 12 h (reflux). The
crude product was purified by column chromatography (benzene–
EtOAc, 9 : 1) followed by recrystallization from benzene to provide
BL-9 (229 mg, 56%) as yellowish orange crystals. M.p. 270–271 ◦C.
1H NMR (300 MHz, CDCl3): d 3.94 (s, 3H), 3.96 (s, 3H), 3.98 (s,
3H), 6.92 (d, J = 7.8 Hz, 1H), 6.96 (ddd, J = 1.2, 7.2, 7.8 Hz,
1H), 7.10 (bs, 2H), 7.17 (ddd, J = 1.5, 1.5, 7.5 Hz, 2H), 7.34
(ddd, J = 1.5, 7.2, 7.5 Hz, 1H), 7.47 (d, J = 8.1 Hz, 1H), 7.51
(d, J = 7.5 Hz, 1H), 7.51 (ddd, J = 1.8, 1.8, 7.5 Hz, 1H), 7.55
(d, J = 7.5 Hz, 1H), 7.62 (ddd, J = 1.5, 8.1, 8.1 Hz, 1H), 7.65
(dd, J = 0.9, 8.1 Hz, 1H), 7.67 (d, J = 8.1 Hz, 2H), 7.73 (ddd,
J = 0.9, 1.5, 7.5 Hz, 1H), 7.78 (dd, J = 1.8, 8.1 Hz, 1H), 7.82
(dd, J = 1.5, 8.1 Hz, 1H), 7.90 (d, J = 1.8 Hz, 1H), 7.91 (d, J =
1.2 Hz, 1H). 13C NMR (75.4 MHz, CDCl3): d 55.85, 56.13, 56.13,
87.70, 88.11, 88.76, 89.56, 91.01, 91.01, 92.76, 93.14, 94.60, 95.25,
110.51, 111.24, 111.93, 111.96, 113.35, 113.37, 113.79, 113.81,
115.50, 115.63, 115.67, 115.67, 115.99, 116.00, 116.03, 116.61,
117.27, 120.64, 121.90, 122.00, 122.24, 123.32, 123.90, 124.41,
125.15, 125.89, 126.12, 127.60, 131.32, 132.23, 133.94, 134.42,
134.60, 134.66, 135.93, 136.72, 159.57, 160.07, 160.07. HR MS
(FAB, positive ion mode) calcd for C52H29N3O3 743.2209, found
743.2215.
2-[[2-Methoxy-4- [[2-methoxy-4- [(2-methoxyphenyl)-ethynyl]-
phenyl]-ethynyl]-phenyl]-ethynyl]-benzonitrile (BL-7). By the gen-
eral procedure the reaction of 13 (372 mg, 0.95 mmol) with 2-
bromobenzonitrile (144 mg, 0.79 mmol) was completed after 12 h
(reflux). The crude product was purified by column chromatog-
raphy (benzene) followed by recrystallization from benzene to
provide BL-7 (121 mg, 31%) as yellow crystals. M.p. 127–128 ◦C.
1H NMR (300 MHz, CDCl3): d 3.93 (s, 3H), 3.96 (s, 3H), 3.97 (s,
3H), 6.92 (d, J = 7.5 Hz, 1H), 6.96 (ddd, J = 1.2, 7.5, 7.5 Hz,
1H), 7.09 (d, J = 1.2 Hz, 2H), 7.16 (dd, J = 1.5, 8.1 Hz, 2H), 7.34
(ddd, J = 1.5, 7.8, 8.1 Hz, 1H), 7.40 (ddd, J = 1.5, 7.8, 7.8 Hz,
1H), 7.47 (d, J = 7.8 Hz, 1H), 7.51 (dd, J = 1.5, 7.5 Hz, 1H), 7.55
(d, J = 7.8 Hz, 1H), 7.56 (ddd, J = 1.2, 7.2, 7.2 Hz, 1H), 7.65
(ddd, J = 0.9, 1.2, 6.0 Hz, 1H), 7.68 (ddd, J = 0.9, 1.5, 6.0 Hz,
1H). 13C NMR (75.4 MHz, CDCl3): d 55.85, 55.96, 56.12, 87.69,
87.81, 91.04, 92.41, 93.15, 94.62, 110.73, 111.57, 111.97, 112.06,
113.38, 113.81, 113.81, 115.14, 115.18, 117.59, 120.65, 123.87,
124.40, 125.07, 125.12, 125.56, 127.36, 132.08, 132.70, 133.06,
133.59, 133.87, 159.94, 159.94, 159.97. HR MS (FAB, positive
ion mode) calcd for C34H23NO3 493.1678, found 493.1682.
Acknowledgements
We thank Dr Yukihiro Shimoi (National Institute of Advanced
Industrial Science and Technology (AIST)) for the DFT and
TD-DFT calculations, and Dr Kazuya Ogawa (Nara Institute
1230 | Org. Biomol. Chem., 2008, 6, 1222–1231
This journal is
The Royal Society of Chemistry 2008
©